Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2023 Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2023 Earnings Call Transcript May 16, 2023

Operator: Good morning and welcome to the Inhibikase Therapeutics First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Alexander Lobo with Stern...